<VariationArchive RecordType="classified" VariationID="453987" VariationName="NC_000005.10:g.(?_177135084)_(177295479_?)del" VariationType="Deletion" Accession="VCV000453987" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2018-05-26" MostRecentSubmission="2018-05-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="454419" VariationID="453987">
      <GeneList>
        <Gene Symbol="LOC126807619" FullName="MED14-independent group 3 enhancer GRCh37_chr5:176696443-176697642" GeneID="126807619" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>5q35.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="177269442" stop="177270641" display_start="177269442" display_stop="177270641" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129995362" FullName="ATAC-STARR-seq lymphoblastoid silent region 16676" GeneID="129995362" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>5q35.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="177159657" stop="177159786" display_start="177159657" display_stop="177159786" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="NSD1" FullName="nuclear receptor binding SET domain protein 1" GeneID="64324" HGNC_ID="HGNC:14234" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q35.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="177131798" stop="177300213" display_start="177131798" display_stop="177300213" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="176560079" stop="176727213" display_start="176560079" display_stop="176727213" Strand="+" />
          </Location>
          <OMIM>606681</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NSD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NSD1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000005.10:g.(?_177135084)_(177295479_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q35.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" innerStart="177135084" innerStop="177295479" display_start="177135084" display_stop="177295479" variantLength="160396" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.(?_177135084)_(177295479_?)del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.(?_177135084)_(177295479_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000005.10:g.(?_177135084)_(177295479_?)del AND Beckwith-Wiedemann syndrome" Accession="RCV000557733" Version="2">
        <ClassifiedConditionList TraitSetID="1134">
          <ClassifiedCondition DB="MedGen" ID="C0004903">Beckwith-Wiedemann syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-09-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-09-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-26" MostRecentSubmission="2018-05-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18505455</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21597970</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25608832</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1134" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="589" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Beckwith-Wiedemann syndrome</ElementValue>
                <XRef ID="Beckwith-Wiedemann+Syndrome/774" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007534" DB="MONDO" />
                <XRef ID="81780002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Exomphalos macroglossia gigantism syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EMG Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BWS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WBS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by neonatal hypoglycemia, macrosomia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly), and ear creases/pits. BWS is considered a clinical spectrum, in which affected individuals may have many of these features or may have only one or two clinical features. Early death may occur from complications of prematurity, hypoglycemia, cardiomyopathy, macroglossia, or tumors. However, the previously reported mortality of 20% is likely an overestimate given better recognition of the disorder along with enhanced treatment options. Macroglossia and macrosomia are generally present at birth but may have postnatal onset. Growth rate slows around age seven to eight years. Hemihyperplasia may affect segmental regions of the body or selected organs and tissues.</Attribute>
                <XRef ID="NBK1394" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3343" />
                <XRef ID="3343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301568</ID>
                <ID Source="BookShelf">NBK1394</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2001">
                <ID Source="pmc">3111049</ID>
              </Citation>
              <Citation Type="general" Abbrev="Italian BWS Association, 2016">
                <ID Source="PubMed">26592461</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32296163</ID>
              </Citation>
              <XRef ID="116" DB="Orphanet" />
              <XRef ID="C0004903" DB="MedGen" />
              <XRef ID="MONDO:0007534" DB="MONDO" />
              <XRef Type="MIM" ID="130650" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1214902" SubmissionDate="2018-04-02" DateLastUpdated="2018-05-26" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1417129|MedGen:C0004903" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000623136" DateUpdated="2018-05-26" DateCreated="2017-12-26" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21597970</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18505455</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25608832</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the NSD1 gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Similar deletions encompassing the entire NSD1 gene have been reported in many individuals affected with Sotos syndrome (PMID: 18505455, 21597970, 25608832). Loss-of-function variants in NSD1 are known to be pathogenic (PMID: 12464997, 14571271, 15942875, 16247291). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NSD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.(?_176562085)_(176722480_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0004903" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1214902" TraitType="Disease" MappingType="XRef" MappingValue="C0004903" MappingRef="MedGen">
        <MedGen CUI="C0004903" Name="Beckwith-Wiedemann syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>